PaLM F2F Minutes 2017-Nov

IHE PaLM Face to Face Meeting, November 13 - 15, 2017 Cagliari, Sardinia IT

Attendees

Name	13-Nov	14-Nov	15-Nov
Gunter Haroske	x	x	x
Jurgen De Decker (tc)	x	x	x
Jim Harrison	x	x	x
Raj Dash	x	x	x
Mary Kennedy	x	x	x
Carolyn Knapik	x	x	x
Riki Merrick	x	x	x
Kenichi Takahashi	x	x	x
François Macary	x	x	x
Alessandro Sulis	x	x	x
Francesca Frexia	x	x	x
Daniel Rutz	x	x	x
Mario Villace	x	x	x
Toon Claeys	x	x	x
Jessica Poisson (tc)	x PM	x PM
Vittorio Meloni	x	x	x
Genichi Kato	x	x	x
Cecilia Mascia	x	x	x
Luca Lianas	x	x	x
Filip Migom	x	x	x
Megumi Kondo	x	x	x
Paolo Anedda	x
Alessandra Gocca	x
Andrea Costaglioli	x PM	x AM
David De Mena (tc)		x
David Clunie (tc)		x AM	x
Pieter De Smet (tc)		x AM	x
Romaric Croes (tc)		x AM
Frank Van Apeldoorn (tc)			x
Ralf Zwoenitzer (tc)			x

• tc indicates attendance via teleconference

Supporting Documents

• Word version of minutes
• Supporting documents See minutes for which document relate to which section

Summary and Action Items (details follow in Minutes)

• TMA

• Need for additional stakeholders from TM domain (nursing, )
• Change requests to base standard attempted for Jan. & May WGMs -> delay until ?
• Pre-adopt approved new features
• Wait for Japan’s expectations this month

• LCC

• Publish for public comment (request sent Nov15 to MJ)
• Public comment period until end January
• Process comments (2nd hour of February or March call)
• Publish TI in June

• SET

• Choose the standard
• Check standard’s coverage (using the 2nd hour of the monthly calls in December and January)
• Request for changes -> delay for approval
• Write Vol 2

• APSR 2.0

• Migrate media wiki content to pubswiki.ihe.net ( tbd KH)
• Publish for TI -> target date January 25

• Digital Pathology

• White paper scheduled
• Skeleton + initial content shared on GoogleGroup Nov 25.
• December 13 call -> assignment chapters/contributors + draft the monthly call calendar for S1 2018
• First draft for January for sharing within PaLM committee and with DICOM WG 26.
• Re-check alignment of specimen representation
• DICOM supplement 122 / HL7 Specimen DAM / IHE PaLM
• Start producing the first set of profiles (image acquisition, image retrieval & display, ordering/reporting, …)
• Join DICOM WG 26 in Helsinki around June 1st to work on the profiles
• 1st profiles for public comment after November meeting?

• LSH

• Waiting confirmation of interest from Roche Diagnostic
• Reactivate and invite other stakeholders to participate.

• PaLM TF Maintenance

• Write the CP (Filip + Riki + François)
• Potentially one or two additional CPs
• CP balloting
• Integration into TF
• Publish release 9.0 in June.

Minutes - Monday, November 15, 2017

Synopsis of PaLM assets and ongoing projects discussed during the meeting:

Summary of milestones set by the meeting:

Thank you to CRS4 for hosting the meeting!

Introductions were given around the table and teleconference for attendees.

(See PaLM_meeting_Cagliari2017_FM_v2.pptx)

Agenda was reviewed with no changes: https://docs.google.com/spreadsheets/d/1Tl6oyF0BxPEMOQ8R3smz_eM6ZboMbZCqwC-pDjwB3x8/edit#gid=0

Other meetings of interest: possible co-meeting with DICOM. ECDP 2018 (European Congress on Digital Pathology) will take place in Helsinki, Finland, May 30^th – June 1^st. http://digitalpathologysociety.org/14th-european-congress-on-digital-pathology-ecdp-2018/

APSR 2.0: (see APSR 2.0 PC Remarks.pptx)

• Gunter shared pdf draft for Public Comment that was published September 2017: http://ihe.net/uploadedFiles/Documents/PaLM/IHE_PaLM_Suppl_APSR_2.0_PC_2017-09-27.pdf
• Art décor tool now used to produce the APSR profile on CDA template (free tool): https://art-decor.org/mediawiki/index.php/Main_Page  
• We will need help from Kai to deal with the OID issue. The annotation comment uses the PCC OID and there is a collision with OIDs due to large volume of projects working in art décor (international patient summary, EPSOS, etc.) and no good central OID management tool at this time.
• The media wiki hosted by Germany is migrating to a new wiki to be used by IHE (pilot project).
• Reason for statusCode of not allowing active for the observation entries
  • Do we reinstate the missing value set, OR
  • Use the statusCode value set and constrain to final and aborted?
• Corrections are handled by full replacement of the entire report (CDA) with link to replacing document. The corrected / changed result is not clearly indicated. Consider either:
  • a header indicator in replacement reports that indicates where the change is, or
  • add a new section that lists all the references to the sections that are changed
    • May not be possible identify the actual correction, as that is often in narrative form.
    • Would be good to (at least) identify which section to focus attention on.
    • Review the base CDA standard for possible solution.
    • Need to consider other changes that are important for patient care (diagnosis change either minor or major error), and those not affecting patient care.

= If implementing this, we should consider the clinical impact of revision as well.

• IHE-Lab extension is in header to the status of the entire report. We will need assistance from Kai to develop a solution.
• Do we need Payer information in header?
  • This was requested by cancer registry.  
  • Could we use this section from PCC or should we add a participant in the header indicating this is insurance?
  • XD-Lab is an open document template, so we can add additional unspecified content (receiver does not need to raise an error if present, but also does not need to consume it) The header level would be the better location for this
  • Do we want to allow 0..* for insurance?  We would need to define what each one means, when sending more than one. This would be ONLY limited to patient member ID and Name/ID for the insurance company. (in Germany public health requests payment from insurance in order to reimburse the pathologist). We need to get a better idea of what elements we need as part of that insurance.
  • Include a note in the accompanying text that intention is just for reference, not the entire insurance related information, leaving the recipient to get more research based on the IDs provided.
• Ask Kai what the difference in the tool is between “includes” or “contains” regarding author in additional observation versus in all other sections. We can then decide which way to proceed. Contains seems more compact.
• Additive: in SpecimenDAM have additive in 2 places (in container and in the processing activity). In APSR we use the processing additive. There may be a difference in the vocabulary between the container (for transport) and the processing additives for preparation of specimen.
• The circular reference is correct, since we can have recursive parent-child relationships.
• ICD-O codes: not all are publically available (but supposed to be).
  • Why not use SCT? They are missing the cancer detail. iPaLM SCT could work on adding gap concepts to SCT. Gunter to bring some examples to PaLM.
  • ICD-O-3 has 1:1 map to SCT. We can research newer concepts.
  • M code has first 4 digits describing the morphology, the /5^th digit describes the behavior part of the tumor. Can you have all behaviors for all morphologies? If not, it will be difficult to validate the codes.
  • Should we allow multiple code systems (SCT and ICD-O codes) in this element?
• High level sections in APSR: would it be valuable to have molecular observations in a separate section instead of using the additional observation? Check with Clinical Genomic regarding CDA templates (Cambridge 2013)